Wyeth Randomized Study: To Evaluate Bapineuzumab (AAB-001) Administered Subcutaneously in Subjects with Alzheimer’s Disease

The PI of this project was:

This project was funded by: Pharma

The term of this project was: March 2010 to December 2012

The number of subjects scanned during this project was: 3